Trial intelligence / Profile preview

Magnesium sulfate versus sublingual nitroglycerin for uterine hypercontractility during labor

IRCT20191106045347N1Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in Uterine hypercontractility comparing Intravenous magnesium sulfate with Sublingual nitroglycerin spray (2 arms). Primary endpoints: Extra uterine contractions, Heart rate deficit and 4 more. Started May 2020; status: completed.

02

Drugs

magnesium sulfatenitroglycerin
03

Conditions

Uterine hypercontractility

Beyond the preview

Go deeper on IRCT20191106045347N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191106045347N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call